These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27018971)

  • 1. Urothelial Dysfunction and Chronic Inflammation in Diabetic Patients with Overactive Bladder.
    Wang CC; Kuo HC
    Low Urin Tract Symptoms; 2017 Sep; 9(3):151-156. PubMed ID: 27018971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial dysfunction and chronic inflammation in patients with spinal cord injuries at different levels and correlation with urodynamic findings.
    Jiang YH; Liu HT; Kuo HC
    Neurourol Urodyn; 2015 Nov; 34(8):757-62. PubMed ID: 25065363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single onabotulinumtoxinA 200U dose improved clinical symptoms but not urothelial dysfunction in neurogenic detrusor overactivity due to spinal cord injury.
    Chen SF; Jiang YH; Kuo HC
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):125-133. PubMed ID: 29482913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.
    Liu HT; Shie JH; Chen SH; Wang YS; Kuo HC
    Urology; 2012 Jul; 80(1):225.e13-8. PubMed ID: 22521193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial Dysfunction, Suburothelial Inflammation and Altered Sensory Protein Expression in Men with Bladder Outlet Obstruction and Various Bladder Dysfunctions: Correlation with Urodynamics.
    Jiang YH; Lee CL; Kuo HC
    J Urol; 2016 Sep; 196(3):831-7. PubMed ID: 26930253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urothelial Barrier Deficits, Suburothelial Inflammation and Altered Sensory Protein Expression in Detrusor Underactivity.
    Jiang YH; Kuo HC
    J Urol; 2017 Jan; 197(1):197-203. PubMed ID: 27436428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Efficacy and Changes of Urothelial Dysfunction after Repeated Detrusor Botulinum Toxin A Injections in Chronic Spinal Cord-Injured Bladder.
    Chen SF; Chang CH; Kuo HC
    Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27249005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pharmacological Mechanism of Diabetes Mellitus-Associated Overactive Bladder and Its Treatment with Botulinum Toxin A.
    Wang CC; Jiang YH; Kuo HC
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of Urothelial Inflammation, Apoptosis, and Junction Protein in Patients with Various Bladder Conditions and Storage Bladder Symptoms Suggest Common Pathway Involved in Underlying Pathophysiology.
    Liu HT; Jiang YH; Kuo HC
    Low Urin Tract Symptoms; 2015 May; 7(2):102-7. PubMed ID: 26663690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
    Lee CL; Jiang YH; Kuo HC
    BJU Int; 2013 Dec; 112(8):1156-62. PubMed ID: 23937072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study.
    Kuo HC; Liu HT; Chuang YC; Birder LA; Chancellor MB
    Eur Urol; 2014 Jun; 65(6):1117-24. PubMed ID: 24555904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of detrusor botulinum toxin a injection on urothelial dysfunction in patients with chronic spinal cord injury: a clinical and immunohistochemistry study before and after treatment.
    Chen SF; Chang CH; Kuo HC
    Spinal Cord; 2016 Oct; 54(10):889-894. PubMed ID: 26832760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
    Jhang JF; Hsu YH; Kuo HC
    Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher levels of cell apoptosis and abnormal E-cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis/painful bladder syndrome.
    Shie JH; Kuo HC
    BJU Int; 2011 Jul; 108(2 Pt 2):E136-41. PubMed ID: 21166752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of Cleaved Synaptosomal-Associated Protein-25 and Decrease of Purinergic Receptors P2X3 in the Bladder Urothelium Influence Efficacy of Botulinum Toxin Treatment for Overactive Bladder Syndrome.
    Liu HT; Chen SH; Chancellor MB; Kuo HC
    PLoS One; 2015; 10(8):e0134803. PubMed ID: 26241848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolterodine activates the prefrontal cortex during bladder filling in OAB patients: a real-time NIRS-urodynamics study.
    Sakakibara ; Tateno F; Yano M; Takahashi O; Sugiyama M; Ogata T; Kishi M; Tsuyusaki Y; Yamamoto T; Uchiyama T; Yamanishi T; Shibata C
    Neurourol Urodyn; 2014 Sep; 33(7):1110-5. PubMed ID: 24038213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
    Kuo YC; Kuo HC
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial dysfunction and increased suburothelial inflammation of urinary bladder are involved in patients with upper urinary tract urolithiasis--clinical and immunohistochemistry study.
    Jiang YH; Kuo HC
    PLoS One; 2014; 9(10):e110754. PubMed ID: 25329457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells.
    Birder LA; Wolf-Johnston AS; Sun Y; Chai TC
    Acta Physiol (Oxf); 2013 Jan; 207(1):123-9. PubMed ID: 22691178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus does not affect the efficacy and safety of intravesical onabotulinumtoxinA injection in patients with refractory detrusor overactivity.
    Wang CC; Liao CH; Kuo HC
    Neurourol Urodyn; 2014 Nov; 33(8):1235-9. PubMed ID: 24115083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.